Arkolith/Insider Trading/PTCT/Form 4

Boulding Mark Elliott

EXEC. VP AND CLOPTC THERAPEUTICS, INC. (PTCT) · full profile →Form 4 · filed May 19, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$203K
Net Open-Market Flow
-$203K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 15, 2026Option exercise(M)3K$25.69$72K108K
May 15, 2026Sell(S)2K$72.08$170K106K
May 15, 2026Sell(S)456$72.67$33K105K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
May 15, 2026Option exercise(M)3K—$020K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001578852-26-000016) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML